NetForum uses cookies to ensure that we give you the best experience on our website. If you continue to use the site, we'll assume that you are happy to receive these cookies on the NetForum website. Read about our cookies.
NetForum Community
Learn. Share. Optimize.
Log in | Sign up now | Submit content | Contact

Attention valued NetForum members:

Due to evolving technology needs and global privacy regulations, we have made the hard decision to suspend the NetForum User Community platform on Friday, November 29, 2019.

After this date, the current NetForum can no longer be reached. Please click here for more information about this decision, what happens next and how to stay in touch with us about the future of the community.

Go to similar content

Radiation burden and associated cancer risk for a typical population to be screened for lung cancer with low-dose CT

Philips CT Clinical Science Philips Healthcare • USA

Perisinakis K, Seimenis I, Tzedakis A, Karantanas A, Damilakis J.

* This article originally appeared in the October 2018 issue of European Radiology.
To estimate (a) organ doses and organ-specific radiation-induced cancer risk from a single low-dose CT (LDCT) for lung cancer screening (LCS) and (b) the theoretical cumulative risk of radiation-induced cancer for a typical cohort to be subjected to repeated annual LCS LDCT.

Sex- and body size-specific organ dose data from scan projection radiography (SPR) and helical CT exposures involved in LCS 256-slice LDCT were determined using Monte Carlo methods. Theoretical life attributable risk (LAR) of radiogenic cancer from a single 256-slice chest LDCT at age 55-80 years and the cumulative LAR of cancer from repeated annual LDCT studies up to age 80 years were estimated and compared to corresponding nominal lifetime intrinsic risks (LIRs) of being diagnosed with cancer.

The effective dose from LCS 256-slice LDCT was estimated to be 0.71 mSv. SPR was found to contribute 6-12% to the total effective dose from chest LDCT. The radiation-cancer LAR from a single LDCT study was found to increase the nominal LIR of cancer in average-size 55-year-old males and females by 0.008% and 0.018%, respectively. Cumulative radiogenic risk of cancer from repeated annual scans from the age of 55-80 years was found to increase the nominal LIR of cancer by 0.13% in males and 0.30% in females.

Modern scanners may offer sub-millisievert LCS LDCT. Cumulative radiation risk from repeated annual 256-slice LDCT LCS examinations was found to minimally aggravate the lifetime intrinsic cancer risk of a typical screening population.

Key Points
  • Effective dose from lung cancer screening low-dose CT may be < 1 mSv.
  • Screening with modern low-dose CT minimally aggravates lifetime cancer induction intrinsic risk.
  • Dosimetry of lung cancer screening low-dose CT should encounter the radiation burden from the localizing scan projection radiography.
  • DLP method may underestimate effective dose from low-dose chest CT by 27%.
For more information about this publication, check out the PubMed listing for this article.

This content has been made possible by NetForum Community.
Share this on: Share your link in twitter Share your link in facebook Share your link on LinkedIn Print Rate this article: Log in to vote

Oct 9, 2018

Rate this:
Log in to vote

Body, chest, dose, low dose, lung cancer, lungs, Oncology, screening

Clinical News
Best Practices
Case Studies
Publications and Abstracts
White Papers
Web seminars and Presentations
Application Tips and FAQ
Try an Application
Business News
Case Studies
White Papers
Web Seminars and Presentations
Utilization Services
Contributing Professionals
Contributing Institutions
Become a Contributor